Search for: "BRISTOL-MYERS SQUIBB" Results 261 - 280 of 863
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Sep 2009, 12:06 pm
Eighteen months after the auction rate securities markets collapsed when Wall Street withdrew its support, companies like Bristol-Myers Squibb Co., Texas Instruments, Corning, and Teva Pharmaceuticals are still suffering from the Wall Street debacle. [read post]
18 Apr 2017, 12:32 pm by Andrew Hamm
.: Ronald Mann previewed next week’s argument in Bristol-Myers Squibb Co. v. [read post]
5 Feb 2019, 7:34 am by Lindsay Offutt
Chairman Chuck Grassley and Ranking Member Ron Wyden sent the invitations to AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., Pfizer and Sanofi. [read post]
20 Aug 2021, 9:58 am by Seyfarth Shaw LLP
By Lennon Haas and Noah Finkel Seyfarth Synopsis:  Since the Supreme Court’s 2017 decision in Bristol-Myers Squibb Co. v. [read post]
20 Dec 2019, 10:15 am by IPWatchdog
This week in Other Barks & Bites: the Inventor Rights Act is introduced into the House of Representatives; House overwhelmingly passes USMCA; major tech companies lobby the European Commission to address holdups in patent licensing; Cox Communications is hit with a billion-dollar verdict in a major copyright case; the USPTO issues a second extension to the effective date of its mandatory electronic trademark filing rule; the Copyright Office appoints Maria Strong as Acting Register of… [read post]
5 Nov 2017, 8:58 pm by Patent Docs
Patent and Trademark Office) - Alexandria, VA November 7, 2017 - "Personal Jurisdiction After Bristol-Myers Squibb: Unresolved Issues, Shifting Plaintiff Strategies" (Strafford) - 1:00 to 2:30 pm (EST) November 9, 2017 - "Leveraging USPTO Examiner Count System: Efficiently Prosecuting Patents, Lowering Prosecution Costs" (Strafford) - 1:00 to 2:30 pm (EST) November 9, 2017 - "Patent Drafting: Trends, Reality and Avoiding Rejections"… [read post]
17 Oct 2018, 10:01 pm by Doug Austin
Jones denied the plaintiff’s Disclosure Motion regarding two documents that defendant Bristol-Myers Squibb (BMS) claimed were privileged and inadvertently disclosed, stating that “[a]lthough BMS might not have followed the precise terms of the Protective Order”, “the one-day delay in sending the privilege log can charitably be described as a...Read the whole entry... [read post]
10 Feb 2019, 9:38 pm by Patent Docs
February 11, 2019 - "The Next Billion-Dollar Acquisition in Pharma -- A Forward-Looking Patent Analysis on Bristol-Myers Squibb Acquiring Celgene" (LexisNexis) - 2:00 pm (ET) February 12, 2019 - "Biotech Patents and Section 101 Rejections: Meeting Patent Eligibility Requirements -- Leveraging Recent Decisions and USPTO Guidance to Overcome Rejections" (Strafford) - 1:00 to 2:30 pm (EST) February 14, 2019 - "Section 112 Issues in IPR Proceedings:… [read post]
26 Jun 2019, 6:36 am by Eileen McDermott
Seventy-two companies and organizations, ranging from Tivo to Bristol-Myers Squibb and from the American Conservative Union to the Alliance of U.S. [read post]
25 Feb 2023, 7:33 pm by Patent Docs
O'Malley (Of Counsel, Irell & Manella LLP), Neema Kumar (Vice President IP, North America, Sandoz), and Serena Farquharson Torres (Executive Director, Assistant General Counsel, Bristol Myers Squibb). [read post]
18 Aug 2021, 12:07 pm by jeffreynewmanadmin
 California Attorney General Rob Bonta today announced a $75 million nationwide settlement with global pharmaceutical company Bristol Myers Squibb (BMS), resolving allegations that BMS underpaid the drug rebates owed to Medi-Cal and other state Medicaid programs. [read post]
11 Jul 2009, 3:25 am
Plavix is made by Sanofi-Aventis and Bristol-Myers Squibb. [read post]
14 Jul 2017, 3:25 am by Walter Olson
Baker, from the just-ended Supreme Court term [Federalist Society podcast with Ted Frank, earlier] Why Bristol-Myers Squibb, the Supreme Court case on state court jurisdiction, “is one of the most important mass tort/product liability decisions ever” [James Beck/Drug & Device Law, earlier] Sandy Hook massacre: “Newtown And Board Of Education Seek Dismissal Of Wrongful Death Lawsuit” [AP/CBS Connecticut] Pennsylvania:… [read post]
20 Jan 2017, 4:26 am by Edith Roberts
In The National Law Journal (subscription or registration required), Tony Mauro reports on one of the grants, Bristol-Myers Squibb Co. v. [read post]
13 Jul 2020, 8:49 am by Joy Waltemath
Chang’s cited Bristol-Myers Squibb to challenge personal jurisdiction, but the court said a jurisdiction analysis is premature. [read post]
31 Jan 2015, 8:47 pm by Mark Summerfield
The issue of what, exactly, is ‘implicitly’ disclosed in a prior art reference arises in a decision of a full bench of the Federal Court issued on 23 January 2015 (Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2) in an appeal relating to a long-running dispute over the validity of a patent covering the antipsychotic drug aripiprazole. [read post]